These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34843733)

  • 1. Factor XII deficiency evaluated by thrombin generation assay.
    Feugray G; Kasonga F; Chamouni P; Barbay V; Fresel M; Hélène Chretien M; Brunel S; Le Cam Duchez V; Billoir P
    Clin Biochem; 2022 Feb; 100():42-47. PubMed ID: 34843733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency].
    Zeerleder S; Asmis L; Redondo M; Sulzer I; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):509-12. PubMed ID: 10517121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients.
    Bachler M; Niederwanger C; Hell T; Höfer J; Gerstmeyr D; Schenk B; Treml B; Fries D
    J Thromb Thrombolysis; 2019 Oct; 48(3):466-474. PubMed ID: 31124034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis of Korean patients with coagulation factor XII deficiency.
    Kwon MJ; Kim HJ; Lee KO; Jung CW; Kim SH
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):308-12. PubMed ID: 20386432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Blood; 1984 May; 63(5):1004-14. PubMed ID: 6713090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding.
    Cai TQ; Wu W; Shin MK; Xu Y; Jochnowitz N; Zhou Y; Hoos L; Bentley R; Strapps W; Thankappan A; Metzger JM; Ogletree ML; Tadin-Strapps M; Seiffert DA; Chen Z
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):893-902. PubMed ID: 26192114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are we to pay attention to factor XII deficiency?].
    Remková A; Remko M
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S63-6. PubMed ID: 27124975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of thrombin generation assay in factor XI deficiency.
    Kasonga F; Feugray G; Chamouni P; Barbay V; Fresel M; Chretien MH; Brunel S; Le Cam Duchez V; Billoir P
    Clin Chim Acta; 2021 Dec; 523():348-354. PubMed ID: 34670127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
    Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
    Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
    Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenotypic and genetic analysis of two pedigrees affected with hereditary coagulation FXII deficiency].
    Li S; Shen C; Shu K; Liu J; Wang X; Li F; Yang X; Zhang Z; Chen B; Jiang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):800-803. PubMed ID: 30512149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.
    Halbmayer WM; Haushofer A; Schön R; Mannhalter C; Strohmer E; Baumgarten K; Fischer M
    Thromb Haemost; 1994 Jan; 71(1):68-72. PubMed ID: 8165648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel homozygous missense mutation (Met527Ile) in a consanguineous marriage family with inherited factor XII deficiency.
    Liu M; Wang H; Lin M; Jin Y; Yang L; Wang M
    Hematology; 2020 Dec; 25(1):502-506. PubMed ID: 33317433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel deleterious mutation in the F12 gene in a Korean family with severe coagulation factor XII deficiency.
    Kim HJ; Kim HJ; Kwon EH; Lee KO; Park IA; Kim SH
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):683-6. PubMed ID: 20729721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry.
    Indirli R; Ferrante E; Scalambrino E; Profka E; Clerici M; Lettera T; Serban AL; Vena W; Pizzocaro A; Bonomi M; Cangiano B; Carosi G; Mazziotti G; Persani L; Lania A; Arosio M; Peyvandi F; Mantovani G; Tripodi A
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1660-e1672. PubMed ID: 33382882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased in vitro thrombin generation and clot stability in human FXII-null blood and plasma.
    Pluthero FG; Ryan C; Williams S; Brandão LR; Kahr WH
    Br J Haematol; 2011 Jan; 152(1):111-2. PubMed ID: 20880114
    [No Abstract]   [Full Text] [Related]  

  • 19. A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
    Ogiwara K; Nogami K; Matsumoto N; Noguchi-Sasaki M; Hirata M; Soeda T; Shima M
    Int J Hematol; 2020 Nov; 112(5):621-630. PubMed ID: 32748217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common C-->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity.
    Endler G; Exner M; Mannhalter C; Meier S; Ruzicka K; Handler S; Panzer S; Wagner O; Quehenberger P
    Thromb Res; 2001 Feb; 101(4):255-60. PubMed ID: 11248286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.